Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant
A Feasibility Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transplantation
5 other identifiers
interventional
30
1 country
1
Brief Summary
This clinical trial tests whether chaplain-delivered compassion centered spiritual health (CCSH) works to improve quality of life in patients receiving a stem cell transplant. Compassion Centered Spiritual Health (CCSH) is a secularized, research-based mindfulness and compassion meditation program designed to expand and strengthen compassion for self and others. Practices include training in attentional stability and increased emotional awareness, as well as targeted reflections to appreciate one's relationship with self and others. By centering the mind, controlling negative thoughts, and cultivating personal resiliency and an inclusive and more accurate understanding of others, Compassion Centered Spiritual Health (CCSH) may help improve response to stress and reduce inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lymphoma
Started Mar 2022
Shorter than P25 for not_applicable lymphoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2022
CompletedResults Posted
Study results publicly available
April 16, 2024
CompletedApril 16, 2024
March 1, 2024
2 months
February 25, 2022
August 31, 2023
March 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Fidelity to Intervention Delivery
Chaplains will deliver between four and eight 30-minute sessions (2-4 times per week) to evaluate the fidelity of implementation (FOI). Administer the (4 min) Scottish Patient Reported Outcome Measure. The Patient Reported Outcome Measure is an 18-item Likert-scale that assesses how a hospitalized patient felt about the pastoral care visit both during the consult and after it. The scale will indicate the following range: 5-25, with higher scores indicating more improvement as a result of the chaplain visit and lower scores indicating less improvement as a result of the chaplain visit.
3 months
Secondary Outcomes (3)
Number of Sessions Completed
Up to 3 months
Percentage of Cognitive Based Compassion Training
Up to 3 months
Responsiveness
Up to 3 months
Study Arms (1)
Supportive Care
EXPERIMENTALPatients undergo 4 to 8 sessions (2-4 per week) of Compassion Centered Spiritual Health (CCSH) over 30 minutes with a chaplain while impatient.
Interventions
Ancillary studies
Deliver or undergo Compassion Centered Spiritual Health (CCSH) session
Eligibility Criteria
You may qualify if:
- PATIENT: Within 6 weeks of scheduled hematopoietic stem cell transplant (HSCT)
- PATIENT: \> 18 years of age
- PATIENT: Speak and read English
- CHAPLAIN: Emory Healthcare Chaplain
You may not qualify if:
- PATIENT: Neurologic or cognitive problems that preclude chaplain-delivered Compassion Centered Spiritual Health (CCSH)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Cancer Institute (NCI)collaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This study was not designed to evaluate efficacy, therefore no statistical analysis was developed or associated with this trial.
Results Point of Contact
- Title
- Dr. Jennifer Mascaro
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Mascaro, PhD
Emory University Hospital/Winship Cancer Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2022
First Posted
March 10, 2022
Study Start
March 21, 2022
Primary Completion
May 25, 2022
Study Completion
May 25, 2022
Last Updated
April 16, 2024
Results First Posted
April 16, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share